Compass Financial Statements From 2010 to 2025
Compass Biotechnologies' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Compass Biotechnologies' valuation are provided below:
Market Capitalization | Earnings Share |
We have found one hundred twenty available fundamental signals for Compass Biotechnologies, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Compass Biotechnologies prevailing
fundamentals against the
fundamentals between
2010 and 2025 to make sure the company is sustainable this year. The current
Market Cap is estimated to decrease to about 1.6
M.
Enterprise Value is estimated to decrease to about 1.6
MCheck out the analysis of
Compass Biotechnologies Correlation against competitors.
For more detail on how to invest in Compass Stock please use our
How to Invest in Compass Biotechnologies guide.
Compass Biotechnologies Balance Sheet | | |
|
Compass Biotechnologies Income Statement | | |
|
Compass Biotechnologies Cash Flow Statement | | |
|
Financial Ratios | | |
|
Compass Biotechnologies Valuation Data | | |
|
About Compass Biotechnologies Financial Statements
Investors use fundamental indicators, such as Compass Biotechnologies' revenue or net income, to determine how well the company is positioned to perform in the future. Although Compass Biotechnologies' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Currently Active Assets on Macroaxis
When determining whether Compass Biotechnologies
offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compass Biotechnologies'
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compass Biotechnologies Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Compass Biotechnologies Stock: Is Real Estate Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost
the valuation of Compass Biotechnologies. If investors know Compass will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compass Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share | Return On Assets |
The market value of Compass Biotechnologies is measured differently than its book value, which is the value of Compass that is recorded on the company's balance sheet. Investors also form their own opinion of Compass Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Compass Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compass Biotechnologies' market value can be influenced by many factors that don't directly affect Compass Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compass Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine
if Compass Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compass Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.